Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate 10X Genomics Inc before investing.

In this article, we go over a few key elements for understanding 10X Genomics Inc’s stock price such as:

• 10X Genomics Inc’s current stock price and volume
• Why 10X Genomics Inc’s stock price changed recently
• Upgrades and downgrades for TXG from analysts
• TXG’s stock price momentum as measured by its relative strength

About 10X Genomics Inc (TXG)

Before we jump into 10X Genomics Inc’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

10x Genomics, Inc. is a life science technology company. The Company's integrated solutions include instruments, consumables and software for analyzing biological systems. Its Chromium platform includes its Chromium X Series, Chromium Connect and legacy Chromium Controller instruments, microfluidic chips and related consumables, which enables throughput analysis of individual biological components. Its Visium platform enables researchers to understand the spatial positions of biological analytes within tissues at high resolution. Its Xenium platform for in situ analysis is designed to give scientists the ability to not only locate and type cells in their tissue context. Its products include Chromium Single Cell Gene Expression, Chromium Single Cell Gene Expression Flex, Chromium Single Cell Immune Profiling, Chromium Single Cell assay for transposase accessible chromatin (ATAC), Chromium Single Cell Multiome ATAC + Gene Expression, Visium Spatial Gene Expression, and others.

Want to learn more about 10X Genomics Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about 10X Genomics Inc.

10X Genomics Inc’s Stock Price as of Market Close

As of September 26, 2024, 4:00 PM, CST, 10X Genomics Inc’s stock price was $22.30.

10X Genomics Inc is up 4.94% from its previous closing price of $21.25.

During the last market session, 10X Genomics Inc’s stock traded between $21.07 and $22.90. Currently, there are 120.07 million shares of 10X Genomics Inc stock available for purchase.

Unfortunately, 10X Genomics Inc’s P/E ratio is not significant enough to use for stock price evaluation. We recommend investors evaluate other financial metrics to understand its overall valuation.

10X Genomics Inc Stock Price History

10X Genomics Inc’s (TXG) price is currently down 4.5% so far this month.

During the month of September, 10X Genomics Inc’s stock price has reached a high of $24.76 and a low of $20.94.

Over the last year, 10X Genomics Inc has hit prices as high as $57.90 and as low as $15.28. Year to date, 10X Genomics Inc’s stock is down 38.8%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused 10X Genomics Inc Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of September 25, 2024, there were 5 analysts who downgraded 10X Genomics Inc’s stock and 10 analysts who upgraded over the last month.

Additionally, you'll want to evaluate 10X Genomics Inc’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on 10X Genomics Inc’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

10X Genomics Inc’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about 10X Genomics Inc (TXG) by visiting AAII Stock Evaluator.

Relative Price Strength of 10X Genomics Inc

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of September 25, 2024, 10X Genomics Inc has a weighted four-quarter relative price strength of -11.99%, which translates to a Momentum Score of 27 and is considered to be Weak.

Want to learn more about how 10X Genomics Inc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

10X Genomics Inc Stock Price: Bottom Line

As of September 26, 2024, 10X Genomics Inc’s stock price is $22.30, which is up 4.94% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like 10X Genomics Inc stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.